Literature DB >> 19754212

Dosimetric comparison of intensity-modulated radiosurgery and helical tomotherapy for the treatment of multiple intracranial metastases.

Lauren Vanderspek1, Glenn Bauman, Jia-Zhu Wang, Slav Yartsev, Cynthia Ménard, Young-Bin Cho, Arno J Mundt, Joshua D Lawson, Kevin T Murphy.   

Abstract

The purpose of this study was to evaluate the dosimetry of single fraction, single-isocenter intensity-modulated radiosurgery (IMRS) plans for multiple intracranial metastases and to compare Helical Tomotherapy (HT). Ten treatment plans with 3-6 brain metastases treated with IMRS were re-planned with HT. The mean number of lesions was 5 and mean PTV 22 cm(3). The prescribed dose was 16-20 Gy. The mean V100% was similar for IMRS and HT, and the mean conformity index was 1.4, mean Paddick confirmity index was 0.7, and mean MDPD was 1.1 for both. The mean gradient index was similar for both. The mean 50% _isodose volume was 179.2 cm(3) for IMRS and 277.0 cm(3) for HT (p=0.01). The mean maximum doses to organs at risk were lower for IMRS except brainstem and right optic nerve. For brain, the integral dose was 5.1 and 6.8 Gy-kg (p<0.001) and mean dose 4.0 and 5.4 Gy (p<0.001) for IMRS and HT, respectively. The mean treatment times were 23 (IMRS) and 41 (HT) minutes. Conformity and homogeneity indices were equivalent and sparing of the organs at risk was clinically acceptable for both IMRS and HT. Though the gradient index was similar for IMRS and HT, the mean 50% isodose volume and integral dose to normal brain were lower for IMRS as was treatment time.

Entities:  

Mesh:

Year:  2009        PMID: 19754212     DOI: 10.1177/153303460900800506

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  3 in total

1.  Use of Helical TomoTherapy for the Focal Hypofractionated Treatment of Limited Brain Metastases in the Initial and Recurrent Setting.

Authors:  Andrew Elson; Ashley Walker; Joseph A Bovi; Christopher Schultz
Journal:  Front Oncol       Date:  2015-02-09       Impact factor: 6.244

2.  Treatment of single or multiple brain metastases by hypofractionated stereotactic radiotherapy using helical tomotherapy.

Authors:  Aiko Nagai; Yuta Shibamoto; Masanori Yoshida; Koichi Wakamatsu; Yuzo Kikuchi
Journal:  Int J Mol Sci       Date:  2014-04-22       Impact factor: 5.923

3.  Evaluation of Hybrid Arc and Volumetric-Modulated Arc Therapy Treatment Plans for Fractionated Stereotactic Intracranial Radiotherapy.

Authors:  Jun Li; David To; Vickie Gunn; Wenyin Shi; Yan Yu; Haisong Liu
Journal:  Technol Cancer Res Treat       Date:  2018-01-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.